X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1410) 1410
Publication (190) 190
Book Chapter (27) 27
Book Review (15) 15
Conference Proceeding (9) 9
Streaming Video (4) 4
Magazine Article (3) 3
Web Resource (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
eculizumab (1171) 1171
index medicus (820) 820
humans (792) 792
female (383) 383
complement (373) 373
male (341) 341
hematology (300) 300
hemolytic-uremic syndrome (297) 297
antibodies, monoclonal, humanized - therapeutic use (296) 296
complement inhibitor eculizumab (288) 288
urology & nephrology (276) 276
adult (253) 253
thrombotic microangiopathy (249) 249
atypical hemolytic uremic syndrome (238) 238
paroxysmal nocturnal hemoglobinuria (195) 195
transplantation (190) 190
middle aged (178) 178
paroxysmal-nocturnal hemoglobinuria (162) 162
treatment outcome (161) 161
diagnosis (159) 159
pediatrics (152) 152
medicine & public health (144) 144
care and treatment (141) 141
child (136) 136
immunology (136) 136
complement activation (135) 135
mutation (130) 130
activation (129) 129
adolescent (127) 127
hemolytic uremic syndrome (127) 127
kidney transplantation (126) 126
thrombosis (125) 125
disease (123) 123
medicine, general & internal (122) 122
therapy (120) 120
hemic and lymphatic diseases (119) 119
young adult (118) 118
children (117) 117
mutations (113) 113
thrombotic thrombocytopenic purpura (113) 113
hemoglobinuria, paroxysmal - drug therapy (112) 112
plasma exchange (111) 111
hemolysis (109) 109
ahus (107) 107
management (107) 107
anemia (106) 106
monoclonal antibodies (106) 106
nephrology (105) 105
animals (103) 103
alternative pathway (99) 99
natural-history (97) 97
aged (94) 94
health aspects (90) 90
pregnancy (90) 90
recurrence (90) 90
abridged index medicus (89) 89
rituximab (85) 85
analysis (84) 84
patients (84) 84
research (82) 82
pnh (81) 81
risk factors (80) 80
child, preschool (78) 78
membranoproliferative glomerulonephritis (78) 78
atypical hemolytic uremic syndrome - drug therapy (77) 77
urologic and male genital diseases (77) 77
inhibitor eculizumab (75) 75
kidneys (75) 75
immunosuppressive agents - therapeutic use (74) 74
oncology (74) 74
retrospective studies (74) 74
article (72) 72
glomerulonephritis (72) 72
thrombocytopenic purpura (72) 72
antibodies (71) 71
case report (71) 71
hemoglobinuria, paroxysmal - diagnosis (70) 70
antibodies, monoclonal, humanized (69) 69
antibodies, monoclonal - therapeutic use (68) 68
antibodies, monoclonal, humanized - administration & dosage (68) 68
dense deposit disease (68) 68
infant (66) 66
c3 glomerulopathy (63) 63
proteins (63) 63
complement inactivating agents - therapeutic use (62) 62
prognosis (61) 61
hemoglobinuria, paroxysmal - complications (60) 60
renal-transplantation (60) 60
complement factor h - genetics (57) 57
complement system proteins - immunology (57) 57
drug therapy (55) 55
hus (55) 55
surgery (55) 55
complement activation - drug effects (53) 53
deficiency (53) 53
dense-deposit disease (53) 53
factor-h (53) 53
hemoglobinuria, paroxysmal - therapy (53) 53
peripheral vascular disease (53) 53
review (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1284) 1284
French (39) 39
German (36) 36
Spanish (32) 32
Russian (17) 17
Japanese (11) 11
Czech (5) 5
Turkish (5) 5
Hungarian (3) 3
Polish (3) 3
Italian (2) 2
Portuguese (2) 2
Dutch (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


RHEUMATOLOGY, ISSN 1462-0324, 07/2016, Volume 55, Issue 7, pp. 1337 - 1340
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 12/2018, Volume 45, Issue 12, pp. 1710 - 1711
Dermatomyositis (DM) is a rare autoimmune disease that belongs to the group of idiopathic inflammatory myopathies (IIM). The usual treatment of DM was based on... 
ECULIZUMAB | POLYMYOSITIS | RHEUMATOLOGY
Journal Article
Kidney International, ISSN 0085-2538, 10/2019, Volume 96, Issue 4, pp. 829 - 833
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells
Journal Article
Anaerobe, ISSN 1075-9964, 09/2019, p. 102099
Fusobacterium nucleatum is a common oral commensal bacterium capable of severe invasive infections. We report a case of a diffuse bilateral pneumopathy with F.... 
Journal Article
Kidney International, ISSN 0085-2538, 09/2019, Volume 96, Issue 3, pp. 761 - 768
Terminal complement inhibition therapy with eculizumab (a humanized monoclonal antibody to C5) has revolutionized the treatment of patients with thrombotic... 
eculizumab | IgG subclasses | thrombotic microangiopathy | ACTIVATION | HEMOLYTIC-UREMIC SYNDROME | COMPLEMENT INHIBITOR ECULIZUMAB | DISEASE | UROLOGY & NEPHROLOGY | OUTCOMES | AHUS
Journal Article
NEFROLOGIA, ISSN 0211-6995, 09/2015, Volume 35, Issue 5, pp. 421 - 447
Journal Article
NEFROLOGIA, ISSN 0211-6995, 2013, Volume 33, Issue 1, pp. 27 - 45
Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in... 
COFACTOR PROTEIN CD46 | Thrombotic microangiopathy | LIVER-KIDNEY TRANSPLANTATION | Complement | RENAL-TRANSPLANTATION | THROMBOTIC THROMBOCYTOPENIC PURPURA | FACTOR-I | PROPHYLACTIC ECULIZUMAB | INHIBITOR ECULIZUMAB | GENE | Atypical hemolytic uremic syndrome | Eculizumab | UROLOGY & NEPHROLOGY | MUTATIONS | COMPLEMENT-FACTOR-H
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 08/2018, Volume 24, Issue 8, pp. 1561 - 1564
Journal Article
NEFROLOGIA, ISSN 0211-6995, 03/2017, Volume 37, Issue 2, pp. 225 - 227
Journal Article
Turkish Nephrology, Dialysis and Transplantation Journal, ISSN 1300-7718, 2018, Volume 27, Issue 3, pp. 308 - 312
Journal Article